In this talk, we will review the types of FGM/C, epidemiology of this exposure, short-term and long-term sequalae and discuss the available behavioral, medical and surgical interventions.

At the end of this webinar learners will be able to: 

• To understand how to identify FGM/C, ask about it and document it
• To understand the clinical implications of FGM/C
• To learn about surgical corrections that have been developed and where to refer patients

Julia Geynisman-Tan is an Assistant Professor in the division of Urogynecology and Pelvic Reconstructive Surgery in the Department of Obstetrics and Gynecology at Northwestern. Her primary role is the care of patients with pelvic floor disorders including women with prolapse, incontinence, postpartum laceration complications, fistulas and congenital anomalies of the GU tract. She is also the fellowship program director and the director of research for the division. She is currently an investigator in 3 federally- funded trials aimed at improving the care for women with urinary incontinence and has grant funding from two industry partners for surgical outcomes trials. She teaches several courses and leads a research small group in the Feinberg School of Medicine. In addition to her work on pelvic floor disorders, Dr. Geynisman-Tan is passionate about caring for survivors of gender-based violence. Dr. Geynisman-Tan has founded the Northwestern ERASE Clinic for survivors of human trafficking and is an asylum evaluator for Physicians for Human Rights. 

 

Lauren Stewart, MD | NYU Langone Health

The American Urogynecologic Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Urogynecologic Society designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Urogynecologic Society (AUGS) requires that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. AUGS mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AUGS seeks to verify that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AUGS is committed to providing learners with high-quality CME.

Faculty Disclosures

The following speakers report no actual or potential conflict of interest in relation to this presentation.

• Julia Geynisman-Tan, MD 

Planner and Staff Disclosures

None of the other planners, reviewers, or AUGS staff have any relevant financial relationships to disclose.